Junshu Zhao
About Junshu Zhao
Junshu Zhao is the Director and CMC Team Lead at Bristol Myers Squibb, with a background in drug formulation and delivery systems.
Current Title and Role at Bristol Myers Squibb
Junshu Zhao is currently serving as the Director and CMC Team Lead at Bristol Myers Squibb in the United States. In this role, Zhao is responsible for leading the Chemistry, Manufacturing, and Controls (CMC) team, ensuring compliance with regulatory guidelines and overseeing the development and manufacturing of pharmaceutical products.
Previous Roles and Experience at Bristol Myers Squibb
Junshu Zhao has held multiple positions at Bristol Myers Squibb, including Associate Scientific Director for 7 months in 2021, Principal Scientist for 4 months from 2020 to 2021, and Senior Research Investigator I, II for 5 years from 2015 to 2020 in New Brunswick, New Jersey. Zhao also served as Research Investigator I, II from 2011 to 2015, also in New Brunswick, NJ.
Education Background
Junshu Zhao received an Executive MBA in Business Administration and Management, General from Columbia Business School, studying from 2022 to 2024. Zhao also earned a PhD in Chemistry from the University of Wisconsin-Madison, studying from 2004 to 2010. Prior to that, Zhao achieved a BS in Chemical Physics from the University of Science and Technology of China from 1999 to 2004.
Industry Contributions and Achievements
Junshu Zhao has made significant contributions to the pharmaceutical industry, including leading the formulation development for a key oncology drug that successfully passed Phase III clinical trials. Zhao is also an inventor, holding a patent for a novel drug delivery system designed to improve the bioavailability of poorly soluble drugs. Additionally, Zhao has authored multiple peer-reviewed articles in top pharmaceutical journals and regularly presents at international pharmaceutical conferences.
Mentorship and Team Involvement
Junshu Zhao actively mentors junior scientists and formulators within Bristol Myers Squibb, promoting a culture of continuous learning and innovation. Zhao has participated in cross-functional teams to streamline the drug development process, significantly reducing the time-to-market for new therapies. Zhao also played a pivotal role in the successful launch of a biologic drug, contributing to its rapid market adoption.